Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-08-24 Sale |
2022-08-26 7:00 pm |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
20,009 | $3.71 | $74,233 | 1,204,338 (Direct) |
View |
| 2022-07-25 Sale |
2022-07-27 9:08 pm |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
20,455 | $4.33 | $88,570 | 1,224,347 (Direct) |
View |
| 2022-06-23 Sale |
2022-06-27 7:00 pm |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
19,855 | $4.34 | $86,171 | 1,244,802 (Direct) |
View |
| 2022-05-20 Sale |
2022-05-24 7:00 pm |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
139,791 | $3.7 | $517,227 | 1,264,657 (Direct) |
View |
| 2022-04-25 Sale |
2022-04-27 7:00 pm |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
8,509 | $3.84 | $32,675 | 1,404,448 (Direct) |
View |
| 2022-03-30 Sale |
2022-04-01 6:00 pm |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
33,686 | $4.84 | $163,040 | 1,412,957 (Direct) |
View |
| 2022-03-25 Sale |
2022-03-29 6:29 pm |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
35,386 | $5.06 | $179,053 | 1,471,897 (Direct) |
View |
| 2022-03-18 Sale |
2022-03-22 9:00 pm |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
82,006 | $5.13 | $420,691 | 1,507,283 (Direct) |
View |
| 2022-03-07 Sale |
2022-03-09 9:45 pm |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
92,324 | $5.52 | $509,628 | 1,589,289 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-04-20 Option Award |
2022-04-22 7:25 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
16,523,184 | $0 | 16,523,184 (Direct) |
View |
| 2022-03-30 Tax Withholding |
2022-04-01 6:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
25,254 | $4.74 | 1,412,957 (Direct) |
View |
Ownership |
2021-10-01 5:50 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
0 | $0 | 12,830,174 (Direct) |
View |